2020
First full-cycle FDA-controlled study
■ ■ ■
COMPANY History
2018
Deepening activities in the field of early development, establishing of a strategic cooperation with the University of Ghent (Belgium) and the joint development of an innovative medical device
2016
First product (Gynecology) in our own full cycle of development
2014
Separation from wholesaler and establishment of CLS-Ukraine LLC
2012
First full-cycle clinical trial
2009
Transformation into SMO/CRO (rescue mission – complex protocols), first FDA-controlled study, expansion to other CIS-countries
2007
Generation of the first Site Network (Obstetrics & Gynecology) and set up as Site Management Organization (SMO)
2005
Founded as a service department of pharmaceutical wholesaler to provide support functions to pharmaceutical business including clinical trials
Contact us
Active Site Network
■ ■ ■ CLS manages national and international networks of clinical sites in several therapeutic areas which allows us to minimize the start-up period. We have active Site Networks in the areas of Obstetrics & Gynecology, Internal Medicine, Oncology, Ophthalmology, Dermatology, Inflammation & Surgery. ■ ■ ■